Reuse and attribution

Licensing

UnifiedACB is open and reproducible where licensing permits. The software license and the source data licenses are separate.

Medication evidence

Public medication-level evidence is shown only from source versions with a verified reuse basis. Each record keeps its source attribution.

JARS — medication-level public representation is included with source attribution. Publication
Yamada-ABS — medication-level public representation is included with source attribution. Publication
BAAS — medication-level public representation is included with source attribution. Publication
Swe-ABS — medication-level public representation is included with source attribution. Publication
GABS — medication-level public representation is included with source attribution. Publication
KABS — medication-level public representation is included with source attribution. Publication
CALS — medication-level public representation is included with source attribution. Publication

Some historical publications are used internally for comparison but are not republished as medication-level tables.

UnifiedACB software and original content

This v3.0 release does not grant a blanket reuse license for UnifiedACB software or original editorial content. Source-derived data retain their source-specific rights and are never automatically relicensed by UnifiedACB. Reuse should follow the rights and attribution information associated with each source.